| Literature DB >> 23481644 |
Kristine Griffett1, Thomas P Burris.
Abstract
Increases in our understanding of the molecular control of circadian rhythms and subsequent signaling pathways has allowed for new therapeutic drug targets to be identified as well as for a better understanding of how to more efficaciously and safely utilize current drugs. Here, we review recent advances in targeting components of the molecular clock in mammals for the development of novel therapeutics as well as describe the impact of the circadian rhythm on drug efficacy and toxicity.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23481644 PMCID: PMC4864859 DOI: 10.1016/j.bmcl.2013.02.015
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823